Trade Shows & Conferences in Boston, Massachusetts

Lessons Learned in Portfolio Management

Date: 28-Oct-14 to 28-Oct-14
Webinar Description: There is no single right way to practice portfolio management in life sciences companies. Organizational maturity, executives’ appetite for analytics, and current budget realities all impact the appropriate level of depth and breadth you should apply to your portfolio processes. In this webinar, we’ll share analytical tools and methods for communicating details about the portfolio that are useful for firms regardless of the current state of their portfolio processes. Learning Objectives: Effective ways to communicate the current status of the portfolio Methods for demonstrating portfolio value accretion and erosion since the last review period Methods for scenario analysis, while letting executives drive the scenario building process to ensure engagement ...

Re-Entering Antibacterial Drug Development Summit

Date: 27-Oct-14 to 29-Oct-14
Several factors including diminishing financial return, lack of new discovery platforms and others, had a cooling effect on pharmaceutical companies' activity in the area of antibacterial drug development. At the same time, we are witnessing the wide spread of resistant bacteria, leading to untreatable infections. "We are facing a huge crisis worldwide not having an antibiotics pipeline," said Dr. Janet Woodcock, Director of CDER at FDA, in her recent interview to NYT. The governments of European countries and the United States have created several incentives for the industry to rise to the challenge. Therefore, many companies are exploring the opportunities to start or re-open their antibacterial departments, or to stimulate the existing research and development. Cambridge ...

2nd The Pharmacovigilance & Risk Management Strategies

Date: 28-Oct-14 to 29-Oct-14
The Pharmacovigilance & Risk Management Strategies Conference is bringing together experts and industry leaders who will discuss the most important issues and challenges regarding Global Pharmacovigilance and Benefit-Risk Analysis. Some of the main topics will include the impact of the new EMA and FDA regulations, Social Media, Adverse Event Reporting, Signal Detection, and Benefit-Risk & Risk Management. This interactive and debate-driven meeting is a one-of-a-kind event, offering delegates the unique opportunity to network and benchmark with their peers in a roundtable format, while discussing the future of Pharmacovigilance and Drug Safety. • Investigate the Current Regulations and Guidelines on USA and EU Pharmacovigilance. • Insight into Building Proactive Risk ...

Targeting Tick-Borne Diseases

Date: 29-Oct-14 to 30-Oct-14
The rapid expansion of tick-borne illness in the Americas and Europe poses great challenges for the prevention and treatment of these diseases, in both humans and animals. Though Lyme Disease continues to be the predominant disease (with estimates of as many as 300,000 new cases every year in the US), new and emerging illnesses are increasingly reported. The cost for treatment of these diseases continues to rise. As humans and animals spend more time in wooded areas, the threat becomes even more urgent. This conference will address the newest science in the pathogenesis of these diseases, along with the latest research into prevention and treatment of these crippling illnesses.

Advances in Prenatal Molecular Diagnostics

Date: 05-Nov-14 to 07-Nov-14
The field of prenatal diagnostics is undergoing rapid and significant change, as a variety of molecular diagnostics are transforming the type and quality of data that can be provided to pregnant women and their physicians. Array-based cytogenetic analysis can provide more detailed and accurate assessment of many genetic conditions compared with traditional karyotyping, both of which rely on samples obtained using invasive procedures. Since obtaining samples invasively, even in the most proficient hands, does involve some risk to the fetus, there has been tremendous interest in non-invasive testing approaches. Next-gen sequencing of cell-free DNA found in maternal blood has been demonstrated to provide highly accurate assessment of fetal aneuploidies, with quite low false positives and ...

POC and mHealth Diagnostics Summit

Date: 05-Nov-14 to 07-Nov-14
The growth and proliferation of point-of-care testing and mobile health devices is an indicator of the transformation in the IVD market, driven by the need to reduce the cost of healthcare and shorten the time required to get test results. A newly emerging DTC segment will meet the needs of consumers who are willing to pay out of pocket to manage their own health information by creating an array of tools designed to enable preventative medicine. This inaugural event will highlight advances in the rapid testing market in two sections: the development of technologies and the progression to the clinical and consumer interface.

18th Annual Boston International Fine Art Show

Date: 13-Nov-14 to 16-Nov-14
18th Annual Boston International Fine Art Show, November 13-16, 2014 Boston, MA - Galleries from Europe, Canada and across the U.S. will offer more than 3,000 original works of art at the 18TH ANNUAL BOSTON INTERNATIONAL FINE ART SHOW, November 13-16, 2014 at The Cyclorama, Boston Center for The Arts, 539 Tremont Street, in Boston’s hip and historic South End. New England’s premier show and sale of contemporary and traditional fine art, featuring paintings, works on paper, sculpture, photography, fine prints, and mixed media. Works on view range from affordable art by today’s emerging artists to museum-quality masterpieces. The show opens with a Gala Preview on Thursday, November 13 from 5:30 to 8:30pm. Weekend show hours are Friday 1:00-8:00pm, Saturday 11:00am-8:00pm and Sunday 11:...

Detecting Fraud in IVD Clinical Trials

Date: 18-Nov-14 to 18-Nov-14
Webinar Description: This webinar will discuss the techniques that Good Clinical Practice (GCP) and those that FDA inspectors may employ to detect fraud. While fraud in clinical trials is rare, Precision will discuss the methodologies and techniques that sponsors need to be aware of to uncover fraud. Further, Precision will explore additional key sponsor responsibilities such as ensuring protocols are adhered to during enrollmentand certifying the data recorded is an accurate representation of that generated, all of which should be addressed through monitoring. Learning Objectives: Understand the difference between surreptitious behavior and sloppiness. How an inspector may "pull threads" to uncover trends in data recording anomalies. How to use monitoring as a means to ...

FAST: Functional Analysis & Screening Technologies Congress

Date: 17-Nov-14 to 19-Nov-14
Join our community of 250+ biologists, screening managers, assay developers, engineers and pharmacologists dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development at 6 conferences: Phenotypic Drug Discovery (Part I & II), Engineering Functional 3D Models, Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology and Physiologically-Relevant Cellular Tumor Models for Drug Discovery.

Update in Internal Medicine

Date: 07-Dec-14 to 13-Dec-14
Location: Boston / United States
In the rapidly evolving world of medicine, state-of-the-art practice requires updated knowledge of the specialties encompassed by internal medicine. This intensive course will provide you with comprehensive, up-to-date, evidence-based therapeutic concepts that you will be able to implement into your daily practice. It covers all major sub-specialties, including: Endocrinology, Hematology, Oncology, Cardiology, Gastroenterology and Hepatology, Infectious Diseases, Nephrology, Pulmonary Diseases, Rheumatology, plus a number of keynotes, special symposia and workshops Scores of attendees continue to comment on the excellence of this course and the fact that this is indeed the best medicine course they have ever attended! “We don’t know how you do it, but this course gets better each ...